Steve Michel | Sutro Biopharma, Inc.

American Society of Hematology (ASH) 2016 – NHL Oral Presentation

American Society of Hematology (ASH) 2016 – NHL Oral Presentation Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin’s Lymphoma Arturo Molina, MD, MS Sutro Biopharma ASH Annual Meeting 2016 ASH NHL Oral...

American Society of Hematology (ASH) 2016 – Poster

Presentations

American Society of Hematology (ASH) 2016 – Poster Discovery and preclinical development of novel CD74-targeting antibody-drug conjugates (ADCs) with significant activity in multiple myeloma (MM) cell lines and xenograft models 2016 DEC ASH MM Poster final no...

Sutro Appoints Shabbir T. Anik Chief Technical Operations Officer

Press Releases

Sutro Appoints Shabbir T. Anik Chief Technical Operations Officer SOUTH SAN FRANCISCO, June 1, 2016 – Sutro Biopharma today announced the appointment of Dr. Shabbir T. Anik to the newly-created position of chief technical operations officer. Dr. Anik brings over 30...

Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development

Press Releases

Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development SOUTH SAN FRANCISCO, Mar. 9, 2016 – Sutro Biopharma today announced the appointment of Arturo Molina, M.D., M.S., FACP as chief...

Next Entries »